Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorDAVIDOVIC, Masa
dc.contributor.authorASANGBEH, Serra Lem
dc.contributor.authorTAGHAVI, Katayoun
dc.contributor.authorDHOKOTERA, Tafadzwa
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorJAQUET, Antoine
dc.contributor.authorMUSICK, Beverly
dc.contributor.authorVAN SCHALKWYK, Cari
dc.contributor.authorSCHWAPPACH, David
dc.contributor.authorROHNER, Eliane
dc.contributor.authorMURENZI, Gad
dc.contributor.authorWOOLS-KALOUSTIAN, Kara
dc.contributor.authorANASTOS, Kathryn
dc.contributor.authorOMENGE, Orang'o Elkanah
dc.contributor.authorBONI, Simon Pierre
dc.contributor.authorDUDA, Stephany N
dc.contributor.authorVON GROOTE, Per
dc.contributor.authorBOHLIUS, Julia
dc.contributor.authorINTERNATIONAL EPIDEMIOLOGY DATABASES TO EVALUATE, Aids
dc.date.accessioned2024-03-18T10:53:00Z
dc.date.available2024-03-18T10:53:00Z
dc.date.issued2024-02-01
dc.identifier.issn1944-7884 (Electronic) 1525-4135 (Print) 1525-4135 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/188835
dc.description.abstractEnBackground:Of women with cervical cancer (CC) and HIV, 85% live in sub-Saharan Africa, where 21% of all CC cases are attributable to HIV infection. We aimed to generate internationally acceptable facility-based indicators to monitor and guide scale up of CC prevention and care services offered on-site or off-site by HIV clinics.Methods:We reviewed the literature and extracted relevant indicators, grouping them into domains along the CC control continuum. From February 2021 to March 2022, we conducted a three-round, online Delphi process to reach consensus on indicators. We invited 106 experts to participate. Through an anonymous, iterative process, participants adapted the indicators to their context (round 1), then rated them for 5 criteria on a 5-point Likert-type scale (rounds 2 and 3) and then ranked their importance (round 3).Results:We reviewed 39 policies from 21 African countries and 7 from international organizations; 72 experts from 15 sub-Saharan Africa countries or international organizations participated in our Delphi process. Response rates were 34% in round 1, 40% in round 2, and 44% in round 3. Experts reached consensus for 17 indicators in the following domains: primary prevention (human papillomavirus prevention, n = 2), secondary prevention (screening, triage, treatment of precancerous lesions, n = 11), tertiary prevention (CC diagnosis and care, n = 2), and long-term impact of the program and linkage to HIV service (n = 2).Conclusion:We recommend that HIV clinics that offer CC control services in sub-Saharan Africa implement the 17 indicators stepwise and adapt them to context to improve monitoring along the CC control cascade.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enWomen living with HIV
dc.subject.enAcquired immunodeficiency syndrome
dc.subject.enEarly detection of cancer
dc.subject.enCervical cancer
dc.subject.enConsensus
dc.subject.enSub- Saharan Africa
dc.title.enFacility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method
dc.title.alternativeJ Acquir Immune Defic Syndren_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1097/QAI.0000000000003343en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed38211958en_US
bordeaux.journalJournal of Acquired Immune Deficiency Syndromes - JAIDSen_US
bordeaux.page170-178en_US
bordeaux.volume95en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue2en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamGHIGS_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDInstitut de Recherche pour le Développementen_US
bordeaux.identifier.funderIDHorizon 2020en_US
bordeaux.identifier.funderIDNational Cancer Instituteen_US
bordeaux.identifier.funderIDNational Institute of Mental Healthen_US
hal.identifierhal-04509106
hal.version1
hal.date.transferred2024-03-18T10:53:04Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Acquired%20Immune%20Deficiency%20Syndromes%20-%20JAIDS&rft.date=2024-02-01&rft.volume=95&rft.issue=2&rft.spage=170-178&rft.epage=170-178&rft.eissn=1944-7884%20(Electronic)%201525-4135%20(Print)%201525-4135%20(Linking)&rft.issn=1944-7884%20(Electronic)%201525-4135%20(Print)%201525-4135%20(Linking)&rft.au=DAVIDOVIC,%20Masa&ASANGBEH,%20Serra%20Lem&TAGHAVI,%20Katayoun&DHOKOTERA,%20Tafadzwa&JAQUET,%20Antoine&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée